Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroki Kabata

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Arerugi = [Allergy]|July 17, 2023
[REGULATORY MECHANISMS OF INNATE AND ACQUIRED IMMUNE SYSTEMS BY TSLP]Hiroki Kabata
American Journal of Respiratory and Critical Care Medicine|May 31, 2024
Unveiling the Neuron-mediated Group 2 Innate Lymphoid Cell Activation in Human AsthmaHiroki Kabata, Shigeharu Ueki
The Journal of Clinical Investigation|March 5, 2019
Neuro-immune crosstalk and allergic inflammationHiroki Kabata, David Artis
Frontiers in Immunology|July 12, 2023
Editorial: Heterogeneity of ILC2sHiroki Kabata, Koichi Fukunaga
Frontiers in Immunology|June 27, 2022
Heterogeneity of ILC2s in the LungsMasato Asaoka, Hiroki Kabata, Koichi Fukunaga
STAR Protocols|January 31, 2024
Protocol for lentiviral vector-based gene transfection in human ILC2sMisato Irie, Hiroki Kabata, Koichi Fukunaga
Immunological Reviews|October 9, 2018
The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanismsHiroki Kabata, Kazuyo Moro, Shigeo Koyasu
Arerugi = [Allergy]|February 25, 2024
[THE INNATE IMMUNE NETWORK AND THERAPEUTIC APPROACHES IN ASTHMA]Rie Baba, Hiroki Kabata, Koichi Fukunaga
Allergology International : Official Journal of the Japanese Society of Allergology|April 3, 2022
Current overview of the role of neuropeptides in ILC2s and future directionsMisato Irie, Kotaro Sasahara, David Artis, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 5, 2022
Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthmaMomoko Kurihara, Hiroki Kabata, Misato Irie, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Arerugi = [Allergy]|July 17, 2023
[REGULATORY MECHANISMS OF INNATE AND ACQUIRED IMMUNE SYSTEMS BY TSLP]Hiroki Kabata
American Journal of Respiratory and Critical Care Medicine|May 31, 2024
Unveiling the Neuron-mediated Group 2 Innate Lymphoid Cell Activation in Human AsthmaHiroki Kabata, Shigeharu Ueki
The Journal of Clinical Investigation|March 5, 2019
Neuro-immune crosstalk and allergic inflammationHiroki Kabata, David Artis
Frontiers in Immunology|July 12, 2023
Editorial: Heterogeneity of ILC2sHiroki Kabata, Koichi Fukunaga
Frontiers in Immunology|June 27, 2022
Heterogeneity of ILC2s in the LungsMasato Asaoka, Hiroki Kabata, Koichi Fukunaga
STAR Protocols|January 31, 2024
Protocol for lentiviral vector-based gene transfection in human ILC2sMisato Irie, Hiroki Kabata, Koichi Fukunaga
Immunological Reviews|October 9, 2018
The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanismsHiroki Kabata, Kazuyo Moro, Shigeo Koyasu
Arerugi = [Allergy]|February 25, 2024
[THE INNATE IMMUNE NETWORK AND THERAPEUTIC APPROACHES IN ASTHMA]Rie Baba, Hiroki Kabata, Koichi Fukunaga
Allergology International : Official Journal of the Japanese Society of Allergology|April 3, 2022
Current overview of the role of neuropeptides in ILC2s and future directionsMisato Irie, Kotaro Sasahara, David Artis, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 5, 2022
Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthmaMomoko Kurihara, Hiroki Kabata, Misato Irie, et al.
Pageof 9